Chicago, Nov. 08, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Artificial Intelligence (AI) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, Neurology, CT, MRI, X - ray, IVD), End User (Hospital, Diagnostic Imaging Center, Diagnostic Laboratory) - Global Forecast to 2027", the global Artificial Intelligence (AI) in Medical Diagnostics Market is projected to reach USD 5.5 billion by 2027 from USD 1.0 billion in 2022, at a CAGR of 39.9% during the forecast period.

Browse in-depth TOC on "AI in Medical Diagnostics Market"
128 - Tables
37 - Figures
178 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22519734

Scope of the Report:

The application of AI in medical diagnostics is growing at a highest rate owing to factors such as rise in government initiatives to drive the adoption of AI-based technologies, high usage of AI solutions by radiologists to reduce workload, the generation of big data, available funding for AI-based start-ups, and the growing number of cross-industry partnerships & collaborations.

However, the lack of trained AI workforce, ambiguity in regulations, and the reluctance among medical practitioners to adopt these solutions are factors expected to restrain the market growth.

On the basis components, AI in medical diagnostics market is segmented into software and services. The services segment dominated the market in 2021, while the software segment is estimated to grow at a higher CAGR during the forecast period. Software solutions provide medical practitioners a chance to gain a competitive edge despite the challenges of being short-staffed and facing increasing imaging scan volumes.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22519734

Based on application, AI in the medical diagnostics market is segmented into in vivo and in vitro diagnostics. The in vivo diagnostics segment commanded the largest share of this market in 2021. The large share of this segment can be attributed to the increase in use of AI solutions by practitioners, as these solutions help reduce human errors and improve treatment efficacy.

Based on end users, the AI in the medical diagnostics market is segmented into hospitals, diagnostic imaging centers, diagnostic laboratories, and other end users. The hospitals segment commanded the largest share of this market in 2021. The large share of this segment can be attributed to the rising number of diagnostic imaging treatments in hospitals, the inclination of hospitals toward the automation and digitization of radiology treatment workflow, adoption of minimally invasive procedures in hospitals to improve the quality of patient care, and the growth in use of advanced imaging modalities to improve workflow efficiency.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=22519734

Geographical Growth Scenario:

The AI in medical diagnostics market has been segmented into four main regional segments: North America, Europe, the Asia Pacific, and the Rest of the World. In 2021, North America accounted for the largest market share of this market. However, the Asia Pacific market is projected to register the highest CAGR of 42.6% during the forecast period. The high growth rate of the Asia Pacific market can primarily be attributed to the growth strategies adopted by key players in emerging markets, better medical diagnostics infrastructure, rising geriatric population, increasing prevalence of cancer, and the implementation of favourable government initiatives to adopt the AI technology.

Key Players:

Prominent players in this market are Microsoft (US), NVIDIA (US), IBM (US), Intel Corporation (US), Google, Inc.(Subsidiary of Alphabet, Inc) (US), Siemens Healthineers (Germany), GE Healthcare (US), Digital Diagnostics, Inc (US), Xilinx (US), InformAI LLC (US), HeartFlow, Inc (US), Enlitic, Inc (US), Day Zero Diagnostics, Inc(US), Aidence (Netherlands), Butterfly Network, Inc. (US), Prognos Health (US), Nanox AI (Israel), Viz.ai, Inc (US), Quibin (Spain), Qure.ai (India), Therapixel (France), Aidoc (Israel), Koninklijke Philips N.V. (Netherlands), Lunit. Inc (South Korea), EchoNous Inc. (US)

Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

Browse Related Reports:

Healthcare Cloud Computing Market

AI in Drug Discovery Market

Molecular Diagnostics Market

Healthcare IT Market

Diagnostic Imaging Market

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com